Bispecific antibodies in cancer therapy
- 26 October 1999
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 11 (5) , 558-562
- https://doi.org/10.1016/s0952-7915(99)00015-1
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Phylogenetic Perspectives in Innate ImmunityScience, 1999
- Effective Phagocytosis and Killing ofCandida albicansvia Targeting FcγRI (CD64) or FcαRI (CD89) on NeutrophilsThe Journal of Infectious Diseases, 1999
- Natural killer cell receptorsCurrent Opinion in Immunology, 1998
- NK CELL RECEPTORSAnnual Review of Immunology, 1998
- Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal AntibodyJNCI Journal of the National Cancer Institute, 1995
- A bispecific antibody prolongs survival in mice bearing lung metastases of syngeneic mammary adenocarcinomaInternational Immunology, 1995
- Single-Chain Antigen-Binding ProteinsScience, 1988
- Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibodyNature, 1985
- Hybrid antibodies can target sites for attack by T cellsNature, 1985
- Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies.The Journal of Experimental Medicine, 1984